EP2465950
K-ras stökkbreytingar og sjúkdómsmeðferð með and-EGFR mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.3.2008EP published:
12.7.2017EP application number:
12154109.8
EP translation filed:
23.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
10.3.2028Expiry date:
10.3.2027Next due date:
31.3.2027
Title:
K-RAS MUTATIONS AND ANTI-EGFR ANTIBODY THERAPY
Timeline
Today
11.3.2008EP application
12.7.2017EP Publication
23.8.2017Translation submitted
15.9.2017Registration published
10.3.2027Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
FREEMAN, DanielAddress:
Newbury Park, CA, US
Name:
JUAN, ToddAddress:
Newbury Park, CA, US
Name:
RADINSKY, RobertAddress:
Thousand Oaks, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
906943 PDate:
13.3.2007Country:
US
Classification
Categories:
C12Q 1/68
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 8.2.2018
Expires: 10.3.2019
Payer: Árnason Faktor
Number: 12
Paid: 7.2.2019
Expires: 10.3.2020
Payer: Árnason Faktor
Number: 13
Paid: 18.2.2020
Expires: 10.3.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.2.2021
Expires: 10.3.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 17.2.2022
Expires: 10.3.2023
Payer: Patice ehf.
Number: 16
Paid: 22.2.2023
Expires: 10.3.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 5.3.2024
Expires: 10.3.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 4.3.2025
Expires: 10.3.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.3.2026
Expires: 10.3.2027
Payer: Árnason Faktor ehf.